Teplizumab and β-cell function in newly diagnosed type 1 diabetes
Ramos EL, Dayan CM, Chatenoud L, et al.
NEJM. Pub. online 18 Oct 2023.
Leggi
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China
Ji L, Ahmann AJ, Ahrén B, et al.
Diabetes Obes Metab. Pub. online 12 Oct 2023.
Leggi
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
Russell-Jones D, Babazono T, Cailleteau R, et al.
The Lancet. Pub. online 17 Oct 2023.
Leggi
Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus
Yuan K, Wu B, Zeng R, et al.
Diabetes Obes Metab. Pub. online 9 Oct 2023.
Leggi
CamAPS FX hybrid closed-loop with ultra-rapid lispro compared with standard lispro in adults with type 1 diabetes: a double-blind, randomized, crossover study
Nwokolo M, Lakshman R, Hartnell S, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2023.
Leggi
Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction
Butt JH, Docherty KF, Kosiborod MN, et al.
J Am Coll Cardiol HF. 2023, 11 (10) 1411–1423.
Leggi
Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy
Lawton J, Kimbell B, Closs M, et al.
Diabetes Technol Ther. Pub. online 5 Oct 2023.
Leggi
Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
Nørgaard SK, Søholm JC, Mathiesen ER, et al.
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00236-X.
Leggi
A european cost-utility analysis of the MiniMedTM 780g advanced hybrid closed-loop system versus intermittently scanned continuous glucose monitoring with multiple daily insulin injections in people living with type 1 diabetes
Jendle J, Buompensiere MI, Saltik AZO, et al.
Diabetes Technol Ther. Pub. online 6 Oct 2023.
Leggi
Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future
Szczerbinski L, Florez JC
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00232-2.
Leggi